(Total Views: 133)
Posted On: 01/30/2018 12:22:00 PM
Post# of 72442
Pfizer has cut 3 cancer drug programs amidst the 14 total drugs it is abandoning.
https://www.fiercebiotech.com/biotech/pfizer-...d=48083647
Perhaps they need to acquire some other novel cancer drug for their pipeline. I wonder if anyone can think of one they could look at. Of course, they'd have to sign a CDA with the company that was developing it.
https://www.fiercebiotech.com/biotech/pfizer-...d=48083647
Perhaps they need to acquire some other novel cancer drug for their pipeline. I wonder if anyone can think of one they could look at. Of course, they'd have to sign a CDA with the company that was developing it.
(3)
(0)Scroll down for more posts ▼
